X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.（XFOR）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
xfor · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$12.00
+223.5% upside
Low
$12.00
Median: $12 · Last Close: $3.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.65 | ↓ 1.57% |
1-day model range: $3.6–$3.7. Peak: $3.7 (-1.57%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · XFOR · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-12-05 | Stifel | Maintains | Buy→Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-29 | Stifel | Maintains | Buy→Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-26 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-02-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on X4 Pharmaceuticals, Inc. (XFOR) stock. Of the recent 44 rating actions, 1 were upgrades and 1 were downgrades. 13 analysts currently cover XFOR.
分析师推荐趋势
XFOR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$10M
↓ 90.6% YoY
Revenue Next Year
$10M
↑ 0.8% YoY
EPS This Year
$-0.73
EPS Next Year
$-0.80
↑ 9.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast XFOR EPS of $-0.73 for the current fiscal year, based on estimates from 3 analysts. The XFOR revenue forecast is $10M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
XFOR 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。XFOR 的共识目标价为 $12.00（+223.5% 上行空间），分析师共识为 Buy。
XFOR 的短期预测（明日）为 $3.65（-1.57%）。
X4 Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 XFOR。XFOR 在 2027 年的整体展望偏积极，在覆盖分析师中约 92% 对应 Buy 共识。
常见问题
XFOR 预测 · 8 个问题根据 13 位华尔街分析师，XFOR 的 12 个月平均目标价为 $12.00，最高 $12.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $3.71，隐含约 +223.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.